Increased soluble FcγRIIIaMφ{symbol} in plasma from patients with coronary artery diseases

Atherosclerosis

Volumn 188, Issue 2, 2006, Pages 377-383

  Masuda, Midori ^a   Miyoshi, Hironori ^a   Kobatake, Shinzo ^b   Nishimura, Noriko ^a   Dong, Xian H ^a   Komiyama, Yutaka ^a   Takahashi, Hakuo ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

^b FUJIFILM Wako Pure Chemical Corporation   (Japan)

Author keywords

Atherosclerosis; Coronary diseases; Fc receptors; Macrophages

Indexed keywords

BIOLOGICAL MARKER; FC GAMMA RECEPTOR TYPE 3A; FC RECEPTOR; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG; FCGR3A PROTEIN, HUMAN; FCGR3B PROTEIN, HUMAN; LEUKOCYTE ANTIGEN;

ADULT; ANGINA PECTORIS; ARTICLE; ATHEROSCLEROSIS; BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; FEMALE; HUMAN; MACROPHAGE ACTIVATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; VASOSPASM; AGED; ANALYSIS OF VARIANCE; BLOOD; COMPARATIVE STUDY; CORONARY ARTERY ATHEROSCLEROSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; GENOTYPE; MACROPHAGE; METABOLISM; MIDDLE AGED;

AGED; ANALYSIS OF VARIANCE; ANTIGENS, CD; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CORONARY ARTERIOSCLEROSIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOTYPE; HUMANS; MACROPHAGES; MALE; MIDDLE AGED; RECEPTORS, IGG;

EID: 33748042280     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2005.10.040     Document Type: Article

References (23)

1. Ravetch J.V., and Perussia B.V. Alternative membrane forms of FcγRIII (CD16) on human natural killer cells and neutrophils. Cell type-specific expression of two genes that differ in single nucleotide substitutions. J Exp Med 170 (1989) 481-497
2. de Haas M., Kleijer M., Minchinton R.M., Roos D., and von dem Borne A.E.G.Kr. Soluble FcγRIIIa is present in plasma and is derived from Natural Killer cells. J Immunol 152 (1994) 900-907
3. Huizinga T.W.J., Kleijer M., Tetteroo P.A., Roos D., and von dem Borne A.E.G.Kr. Biallelic neutrophil NA-antigen system is associated with a polymorphism on the phospho-inositol-linked Fcγ receptor III (CD16). Blood 75 (1990) 213-217
4. Harrison D., Phillips J.H., and Lanier L.L. Involvement of a metalloprotease in spontaneous and phorbol ester-induced release of natural killer cell-associated FcγRIII (CD16-II). J Immunol 147 (1991) 3459-3465
5. Levy P.C., Utell M.J., Fleit H.B., Roberts N.J., Ryan D.H., and Looney R.J. Characterization of human alveolar macrophages Fcγ Receptor III: a transmembrane glycoprotein that is shed under in vitro culture conditions. Am J Resp Cell Mol Biol 5 (1991) 307-314
6. Huizinga T.W.J., de Haas M., van Oers M.H., et al. The plasma concentration of soluble FcγRIII is related to production of neutrophils. Br J Haematol 87 (1994) 459-463
7. Homburg C.H.E., de Haas M., von dem Borne A.E.G.K., Verhoeven A.J., Reutelingsperger C.P.M., and Roos D. Human neutrophils lose their surface FcγRIII and acquire Annexin V binding sites during apoptosis in vitro. Blood 85 (1995) 532-540
8. Middelhoven P.J., van Buul J.D., Hordijk P.L., and Roos D. Different proteolytic mechanisms involved in Fcγ RIIIb shedding from human neutrophils. Clin Exp Immunol 125 (2001) 169-175
9. Ross R. Cell biology of atherosclerosis. Annu Rev Physiol 57 (1995) 791-804
10. van der Wal A.C., Das P.K., Tigges A.J., and Becker A.E. Macrophage differentiation in atherosclerosis: an in situ immunohistochemical analysis in humans. Am J Pathol 141 (1992) 161-168
11. Rothe G., Gabriel H., Kovacs E., et al. Peripheral blood mononuclear phagocyte subpopulations as cellular markers in hypercholesterolemia. Arterioscler Thromb 16 (1996) 1437-1447
12. Ratcliffe N.R., Kennedy S.M., and Morganelli P.M. Immunocytochemical detection of Fcγ receptors in human atherosclerotic lesions. Immunol Lett 77 (2001) 169-174
13. Kiener P.A., Ranking B.M., Davis P.M., Yocum S.A., Warr G.A., and Grove R.I. Immune complexes of LDL induce atherogenic responses in human monocytic cells. Arterioscler Thromb 15 (1995) 990-999
14. Sautès C., Teillaud C., Mazieres N., et al. Soluble Fcγ receptors (sFcγR). Detection in biological fluids; production of a murine recombinant sFcγR biologically active in vitro and in vivo. Immunobiology 185 (1992) 207-221
15. Galon J., Moldovan I., Galinha A., et al. Identification of the cleavage site of plasma soluble Fcγ receptor type III (CD16). Eur J Immunol 28 (1998) 2101-2107
16. Koene H.R., de Haas M., Kleijer M., Roos D., and von dem Borne A.E.G.Kr. NA-phenotype-dependent differences in neutrophil FcγRIIIb expression cause differences in plasma levels of soluble FcγRIII. Br J Haematol 93 (1996) 235-241
17. Masuda M., Morimoto T., Kobatake S., et al. Measurement of soluble Fcγ receptor type IIIa derived from macrophages in plasma: increase in patients with rheumatoid arthritis. Clin Exp Immunol 132 (2003) 477-484
18. Judkins M.P. Selective coronary angiography: a transcutaneous approch. Radiology 89 (1967) 815-824
19. Austen W.G., Edwards J.E., Frye R.L., et al. AHA Committee Report: a reporting system on patients evaluated for coronary artery disease: report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association. Circulation 51 Suppl. (1975) 5-40
20. Koene H.R., Kleijer M., Roos D., de Haas M., and von dem Borne A.E.G.Kr. FcγRIIIB gene duplication: evidence for presence and expression of three distinct FcγRIIIB genes in NA(1+,2+)SH(+) individuals. Blood 91 (1998) 673-679
21. de Haas M., Kleijer M., Roos D., and von dem Borne A.E.G.Kr. Characterization of MAbs of the CD16 cluster and six newly generation CD16 MAbs. In: Schlossmann S.F., Boumsell L., Gilks W., et al. (Eds). Leukocyte typing V (1995), Oxford University Press, Oxford 811-817
22. Plutzky J. Inflammatory pathways in atherosclerosis and acute coronary syndromes. Am J Cardiol 88 (2001) 10K-15K
23. Gabay Q., and Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340 (1999) 448-454